Cell-Easy strengthens executive team with two new highly experienced members
Seekyo raises over €650,000 from business angels and Bpifrance
Advent France Biotechnology appoints Alejo Chorny, PhD, as operating partner and head of new Spanish operations
AELIX Therapeutics presents positive results from randomized placebo-controlled phase I/IIa therapeutic HIV vaccine clinical trial
• Investigational AELIX HTI vaccine leads to prolonged period without antiretroviral treatment (ART)
• Vaccine-induced immune T cell responses significantly correlate with prolonged time off ART
• Results support development of combination strategies based on HTI vaccine to control HIV – without the need for ongoing antiretroviral medication